Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors

NCT07671534 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor Cancer

Interventions

DRUG: Gemcitabine
DRUG: Mitomycin C
DRUG: Thalidomide

Sponsor

Sarcoma Oncology Research Center, LLC